The company noted that Wegovy is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise ...
Novo Nordisk’s obesity drug Wegovy cut the risk of severe complications in patients with a common form of heart failure ... s efforts to expand the label for the blockbuster treatment.